
Being a good corporate citizen is no longer a “nice-to-have” for any business worldwide. Long gone are the days when companies could “do good, and talk about it,” often in terms of philanthropy and public relations campaigns. No disclosures, no metrics, no information on compliance.
Even before the COVID-19 pandemic, corporate investment had largely moved away from funding R&D for intractable killers like malaria, antimicrobial resistance and tuberculosis.
QIAGEN is among the companies actively exploring new models to make sustainable investments in global health.
Epidemiologists say the early warnings of the next pandemic will likely come from resource-constrained locations.
Sustainable investment will yield returns that can be measured across many bottom lines – most crucially a better quality of life for millions of people around the world.